1461P Impact of first-line (1L) therapy on outcomes of adult patients (pts) with metastatic MiT family translocation renal cell carcinomas (TRCC) treated in the contemporary immune checkpoint therapy (ICT) era
| Autor: | Thouvenin, J., Alhalabi, O., Carlo, M., Carril Ajuria, L., Bakouny, Z., Martinez Chanza, N., Negrier, S., Campedel, L., Bilen, M.A., Borchiellini, D., Chahoud, J., Vano, Y-A., Lodi, M., Barthelemy, P., Viswanathan, S.R., Msaouel, P., Choueiri, T.K., Albiges, L., Tannir, N., Malouf, G. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1213-S1214 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|